Pericles Calias
29Patents
7h-index
54Co-inventors
72Inventor score
Filing activity: Dec 22, 1999 → Nov 14, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6521223B1 | Single phase gels for the prevention of adhesions | Chemistry; Metallurgy | 148 | Expired |
| US6610669B1 | Water insoluble derivatives of polyanionic polysaccharides | Human Necessities | 38 | Expired |
| US8545837B2 | Methods and compositions for CNS delivery of iduronate-2-sulfatase | Human Necessities | 27 | Active |
| US9320711B2 | Methods and compositions for CNS delivery of heparan N-sulfatase | Human Necessities | 18 | Active |
| US6749865B2 | Modification of biopolymers for improved drug delivery | Emerging Cross-Sectional Technologies | 18 | Expired |
| US9283181B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 18 | Active |
| US9220677B2 | Methods and compositions for CNS delivery of iduronate-2-sulfatase | Chemistry; Metallurgy | 13 | Active |
| US8945542B2 | Methods for treating lysosomal acid lipase deficiency | Human Necessities | 7 | Active |
| US7189413B2 | Drug delivery of proteins from polymeric blends | Human Necessities | 7 | Expired |
| US10456454B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 6 | Active |
| US9814764B2 | Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidase | Chemistry; Metallurgy | 6 | Active |
| US9770410B2 | Methods and compositions for CNS delivery of arylsulfatase A | Human Necessities | 6 | Active |
| US11065308B2 | Methods and compositions for CNS delivery of heparan n-sulfatase | Chemistry; Metallurgy | 5 | Active |
| US10660944B2 | Stable formulations for CNS delivery of arylsulfatase A | Chemistry; Metallurgy | 3 | Active |
| US7417021B2 | Biologically active conjugate of a biopolymer and therapeutic agent | Emerging Cross-Sectional Technologies | 3 | Expired |
| US11260112B2 | Methods and compositions for CNS delivery of iduronate-2-sulfatase | Chemistry; Metallurgy | 2 | Active |
| US11471516B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 1 | Active |
| US7456220B2 | Immunodulatory compositions and methods of use thereof | Emerging Cross-Sectional Technologies | 1 | Expired |
| US11065307B2 | Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moiety | Chemistry; Metallurgy | 1 | Active |
| US11504515B2 | Access port system with self-adjusting catheter length | Human Necessities | 1 | Active |
| US12161702B2 | Methods and compositions for CNS delivery of heparan N-sulfatase | Chemistry; Metallurgy | 0 | Active |
| US11986616B2 | Access port system for intrathecal drug delivery with self-adjusting catheter length | Human Necessities | 0 | Active |
| US12121569B2 | Methods and compositions for CNS delivery of iduronate-2-sulfatase | Chemistry; Metallurgy | 0 | Active |
| US12409210B2 | CNS delivery of therapeutic agents | Chemistry; Metallurgy | 0 | Active |
| US12168041B2 | Methods and compositions for CNS delivery of arylsulfatase A | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.